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Abstract 
RhoBTB1 is one of the three members of the 
RhoBTB family.  
All RhoBTB proteins are characterized by a GTPase 
domain followed by a proline-rich region, a tandem 
of two BTB domains and a C-terminal putative 
RING finger domain. RHOBTB1 is a putative 
tumour suppressor gene. Expression of RHOBTB1 
has been found decreased in diverse tumors 
including kidney, breast, stomach and colon cancers 
and head and neck squamous cell carcinomas. 
RhoBTB1 is a component of Cullin 3-dependent 
ubiquitin ligase complexes but its role in 
tumorigenesis is unknown. 
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Identity 
HGNC (Hugo): RHOBTB1 
Location: 10q21.2 
Other names: KIAA0740, MGC33059, 
MGC33841 
DNA/RNA 
Description 
The RHOBTB1 gene spans over 132 Kbp genomic 
DNA and consists of 14 exons, 9 coding exons and 
5 more exons in the 5'UTR (Figure 1). The coding 
sequence of RHOBTB1 is 2091 nucleotides long 
(Ramos et al., 2002). The promoter region has a high 
GC content with numerous CpG islands. The 
RHOBTB1 locus has binding sites for retinoid X 
receptor and PPARA (peroxisome proliferator-
activated receptor- α, as demonstrated by chromatin 
immunoprecipitation (Pelham et al., 2012). 
Transcription 
Based on EST sequence analyses there are 
transcription variants that arise from the use of 
alternative promoters and alternative splicing, but 
none of the transcripts affects the coding region. 
Gene structure of RHOBTB1. Boxes represent exons. The coding region is represented in blue. For simplicity very large introns 
in the 5'UTR have been shortened (indicated by discontinuous lines) 
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Architecture of RhoBTB proteins. The figure shows the three human (Hs) RhoBTB subfamily members as well as the Drosophila 
(Dm) and Dictyostelium (Dd) orthologues. The simplified phylogenetic tree on the left illustrates the relationship among the 
proteins (overall percentage similarity between branches). The different domains are indicated with colours. 
 
Protein 
Note 
RhoBTB1 is one of the three members of the 
RhoBTB family in vertebrates. The RhoBTB family 
was identified during the study of the genes encoding 
Rho-related proteins in the lower eukaryote 
Dictyostelium discoideum (Rivero et al., 2002). All 
three RhoBTB proteins may be implicated in 
tumorigenesis. 
Description 
RhoBTB1 is 696 amino acids long. All RhoBTB 
proteins share the same domain architecture: a 
GTPase domain is followed by a proline-rich region, 
a tandem of two BTB domains and a C-terminal 
region (Figure 2). 
The GTPase domain is Rho-related and contains a 
Rho insert that is longer than usual, two insertions 
and one deletion, as well as a few deviations from 
the GTPase consensus of most Rho GTPases. In 
analogy to RhoBTB2, the GTPase domain of 
RhoBTB1 is likely to bind GTP (Manjarrez et al., 
2014). 
The proline-rich region links the GTPase to the first 
BTB domain. This region could act as a SH3 
domain-binding site. 
The BTB domain (broad complex, tramtract and 
bric-a-brac) is an evolutionary conserved protein-
protein interaction domain that participates in 
homomeric and heteromeric associations with other 
BTB domains. The BTB domain was also identified 
as a component of multimeric cullin3-dependent 
ubiquitin ligase complexes. The first BTB domain is 
bipartite, being interrupted by an insertion of 
unknown function. The BTB domains of RhoBTB 
allow the formation of homodimers and of 
heterodimers with other proteins of the RhoBTB 
family (Berthold et al., 2008). 
The C-terminus is a region conserved in all members 
of the RhoBTB subfamily. It predictably folds as 4 
consecutive alpha-helices and one beta-strand and 
may constitute a RING finger domain (Manjarrez et 
al., 2014). Many RING finger domains function as 
ubiquitin ligases. RhoBTB1 does not bear a CAAX 
motif that is typical for classical Rho GTPases and 
serves for localization of the protein to membranes. 
Expression 
RHOBTB1 is ubiquitously expressed, with high 
levels detected in skeletal muscle, placenta, stomach, 
kidney, testis, ovary, uterus and adrenal gland. The 
gene is also expressed in foetal tissues (Ramos et al., 
2002; Nagase et al., 1998). 
Expression of RHOBTB1 has been found decreased 
in kidney, breast and stomach tumors in a cancer 
profiling array (Berthold et al., 2008), in 37% of 46 
head and neck squamous cell carcinomas (Beder et 
al., 2006) and in colon cancer tissues (Xu et al., 
2013). 
RHOBTB1 is a target of the microRNA MIR31- 
(Alder et al., 2012; Xu et al., 2013). 
Localisation 
The localisation of endogenous RhoBTB1 has not 
been investigated. In cells expressing RhoBTB1 
ectopically the protein tends to form aggregates in 
the cytoplasm (Aspenström et al., 2004). 
Function 
RHOBTB1 has been proposed as a candidate tumour 
suppressor gene (Beder et al., 2006). The 
mechanisms by which RhoBTB proteins in general 
exert this and other roles remain speculative. Much 
of what we know about RhoBTB2 may be made 
extensive to RhoBTB1 because of their similarity. 
RhoBTB1 binds to cullin3 and by analogy to 
RhoBTB2 and RhoBTB3 may constitute ubiquitin 
ligase complexes. RhoBTB proteins appear to exist 
in an inactive state through an intramolecular 
interaction of the BTB domain region with the 
GTPase domain (Berthold et al., 2008). This model 
has been refined recently for RhoBTB2 to show that 
the HSP90AA1 (Hsp90) chaperone machinery 
unlocks RhoBTB, enabling GTP binding and 
interaction with Cullin 3 and the COPS8 (COP9) 
signalosome. COP9 deneddylates Cullin 3 and 
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stabilizes the complex (Manjarrez et al. 2014). 
Considering the high degree of similarity between 
RhoBTB2 and RhoBTB1, this mechanism is very 
likely to apply to RhoBTB1 too. 
RHOBTB1 has been identified as a target gene of the 
nuclear hormone receptor PPARG. RhoBTB1 
mRNA and protein levels are decreased in the aorta 
of mice expressing a dominant negative PPARG. 
These mice also present a concomitant decrease in 
Cullin 3, and it has been proposed that RhoBTB1 
regulates Cullin 3 levels or activity, which in turn 
regulates RHOA. turnover in smooth muscle. 
RhoBTB1 emerges as a component of a signaling 
mechanism that regulates vascular function and 
blood pressure (Pelham et al., 2012). 
RhoBTB1, like RhoBTB2, is required for expression 
of the chemokine CXCL14 in keratinocytes 
independently of Cullin3-mediated protein 
degradation (McKinnon et al., 2008). 
RhoBTB1 displays only a moderate influence on the 
morphology and actin organisation of porcine aortic 
endothelial cells upon ectopic expression. It does not 
interact with the GTPase-binding domain of WASP, 
PAK1 or RTKN (Rhotekin), which are well-known 
effectors of many typical Rho GTPases (Aspenstrom 
et al., 2004). 
RhoBTB1, like RhoBTB2 and RhoBTB3, interacts 
with LLRC41 (leucine rich repeat containing 41, 
MUF1). MUF-1 is a nuclear protein and carries a 
BC-box that functions as a linker in multicomponent 
Cullin 5-dependent ubiquitin ligase complexes 
(Schenková et al., 2012). MUF1 may be a substrate 
for RhoBTB-Cullin 3 ubiquitin ligase complexes. 
The function of MUF1 is unknown, but it is 
suspected to be involved in the DNA damage 
response 
Homology 
There are three RhoBTB proteins in vertebrates: 
RhoBTB1, RhoBTB2 and RhoBTB3 (Figure 2). 
RhoBTB1 is very similar to RhoBTB2, while 
RhoBTB3 displays very low similarity to these. 
Orthologues have been found in amoebae and in 
insects but they are absent in plants and fungi. 
Mutations 
No pathogenic mutations have been identified to 
date. 
Implicated in 
Head and neck squamous cell 
carcinoma 
RHOBTB1 resides in a hotspot region with high 
frequency of allelic loss in HNSCCs. Loss of 
heterozygosity at the RHOBTB1 locus was 
identified in 12 of 52 tumour samples. RHOBTB1 
showed decreased expression levels in 37% of 46 
tumour samples and all informative low-expression 
samples displayed loss of heterozygosity. Three 
silent nucleotide changes were found in a mutation 
analysis (Beder et al., 2006). 
Oncogenesis 
RhoBTB1, along with RhoBTB2, seems to be 
required for expression of the chemokine CXCL14 
(McKinnon et al., 2008).  
CXCL14 controls leukocyte migration and 
angiogenesis and its expression is frequently lost in 
diverse epithelial tumours, including most HNSCCs. 
Colon cancer 
RhoBTB1 levels were found decreased in colon 
cancer specimens using immunohistochemistry and 
Western blot. RHOBTB1 was identified as a target 
of miR-31 using bioinformatics tools, and the effect 
of miR-31 was verified experimentally. 
Downregulation of RHOBTB1 is responsible for the 
tumor promoting effects of miR-31. Silencing of 
RHOBTB1 in the colon cancer cell line HT29 
increases cell proliferation and promotes cell clonal 
growth, mimicking the effects of increased miR-31 
expression (Xu et al., 2013). 
Esophageal cancer 
Overexpression of miR-31 in esophagus caused by 
zinc deficiency was found associated to down-
regulation of RHOBTB1, which was identified as a 
target gene of miR-31. Zinc deficiency is a risk 
factor for the development of esophageal squamous 
cell carcinoma (Alder et al., 2012). 
Various cancers including breast, 
kidney and stomach 
Expression of RHOBTB1 was found moderately but 
significantly decreased in kidney, breast and 
stomach tumour samples in a cancer profiling array. 
The decrease affected to 80% of kidney and to 58% 
of breast cancer samples.  
The expression changes correlated with those of 
CUL3 in the same samples (Berthold et al., 2008) 
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